Pre-order Enquiry
Request Free Sample
COVID-19's impact to Global Neurologic Disorders Therapeutics Market Research Report 2020, Forecast to 2025
SKU ID : MMI-16193664 | Publishing Date : 20-Aug-2020 | No. of pages : 132
Request Sample
Request Customization
Check DiscountsDetailed TOC of COVID-19's impact to Global Neurologic Disorders Therapeutics Market Research Report 2020, Forecast to 2025
Table of ContentsGlobal Neurologic Disorders Therapeutics Market Research Report 2020, Forecast to 2025
1 Market Overview
1.1 Neurologic Disorders Therapeutics Definition
1.1.1 Analysis of Macroeconomic Indicators
1.1.2 Years Considered
1.2 Neurologic Disorders Therapeutics Segment by Type
1.2.1 Central Nervous System (CNS)
1.2.2 Peripheral Nervous System (PNS)
1.3 Market Analysis by Application
1.3.1 Paralysis
1.3.2 Muscle Weakness
1.3.3 Poor Coordination
1.3.4 Loss of Sensation
1.3.5 Seizures
1.3.6 Confusion
1.3.7 Pain and Altered Levels of Consciousness
1.4 Overview of Global Neurologic Disorders Therapeutics Market
1.4.1 Global Neurologic Disorders Therapeutics Revenue (2015-2025)
1.4.2 Global Neurologic Disorders Therapeutics Production and Capacity (2015-2025)
1.4.3 North America Neurologic Disorders Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe Neurologic Disorders Therapeutics Status and Prospect (2015-2025)
1.4.5 Japan Neurologic Disorders Therapeutics Status and Prospect (2014-2025)
1.4.6 China Neurologic Disorders Therapeutics Status and Prospect (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.5.4 Porter's Five Forces Analysis
1.5.5 SWOT Analysis
1.6 Coronavirus Disease 2019 (Covid-19): Neurologic Disorders Therapeutics Industry Impact
1.6.1 How the Covid-19 is Affecting the Neurologic Disorders Therapeutics Industry
1.6.2 Neurologic Disorders Therapeutics Business Impact Assessment - Covid-19
1.6.3 Market Trends and Neurologic Disorders Therapeutics Potential Opportunities in the COVID-19 Landscape
1.6.4 Measures / Proposal against Covid-19
2 Global Neurologic Disorders Therapeutics Market Competition by Manufacturer
2.1 Global Neurologic Disorders Therapeutics Sales and Market Share by Manufacturer (2018-2020)
2.2 Global Neurologic Disorders Therapeutics Revenue and Market Share by Manufacturer (2018-2020)
2.3 Global Neurologic Disorders Therapeutics Industry Concentration Ratio (CR5 and HHI)
2.4 Top 5 Neurologic Disorders Therapeutics Manufacturer Market Share
2.5 Top 10 Neurologic Disorders Therapeutics Manufacturer Market Share
2.6 Date of Key Manufacturers Enter into Neurologic Disorders Therapeutics Market
2.7 Key Manufacturers Neurologic Disorders Therapeutics Product Offered
2.8 Mergers & Acquisitions Planning
3 Analysis of Neurologic Disorders Therapeutics Industry Key Manufacturers
3.1 Biogen Inc.
3.1.1 Company Details
3.1.2 Product Information
3.1.3 Biogen Inc. Neurologic Disorders Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.1.4 Main Business Overview
3.1.5 Biogen Inc. News
3.2 F. Hoffmann-La Roche Ltd.
3.2.1 Company Details
3.2.2 Product Information
3.2.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.2.4 Main Business Overview
3.2.5 F. Hoffmann-La Roche Ltd. News
3.3 Johnson & Johnson Services Inc.
3.3.1 Company Details
3.3.2 Product Information
3.3.3 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.3.4 Main Business Overview
3.3.5 Johnson & Johnson Services Inc. News
3.4 Novartis AG
3.4.1 Company Details
3.4.2 Product Information
3.4.3 Novartis AG Neurologic Disorders Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.4.4 Main Business Overview
3.4.5 Novartis AG News
3.5 Pfizer Inc.
3.5.1 Company Details
3.5.2 Product Information
3.5.3 Pfizer Inc. Neurologic Disorders Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
3.5.4 Main Business Overview
3.5.5 Pfizer Inc. News
4 Global Neurologic Disorders Therapeutics Market Size Categorized by Regions (2015-2020)
4.1 Global Neurologic Disorders Therapeutics Sales Market Share by Region
4.2 Global Neurologic Disorders Therapeutics Revenue Market Share by Region (2015-2019)
4.3 Global Neurologic Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Neurologic Disorders Therapeutics Market Size Detail
4.4.1 North America Neurologic Disorders Therapeutics Sales Growth Rate (2015-2020)
4.4.2 North America Neurologic Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Neurologic Disorders Therapeutics Market Size Detail
4.5.1 Europe Neurologic Disorders Therapeutics Sales Growth Rate (2015-2020)
4.5.2 Europe Neurologic Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Neurologic Disorders Therapeutics Market Size Detail
4.6.1 Japan Neurologic Disorders Therapeutics Sales Growth Rate (2015-2020)
4.6.2 Japan Neurologic Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Neurologic Disorders Therapeutics Market Size Detail
4.7.1 China Neurologic Disorders Therapeutics Sales Growth Rate (2015-2020)
4.7.2 China Neurologic Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
5 Global Neurologic Disorders Therapeutics Market Segment by Type
5.1 Global Neurologic Disorders Therapeutics Revenue, Sales and Market Share by Type (2015-2020)
5.1.1 Global Neurologic Disorders Therapeutics Sales and Market Share by Type (2015-2020)
5.1.2 Global Neurologic Disorders Therapeutics Revenue and Market Share by Type (2015-2020)
5.2 Central Nervous System (CNS) Sales Growth Rate and Price
5.2.1 Global Central Nervous System (CNS) Sales Growth Rate (2015-2020)
5.2.2 Global Central Nervous System (CNS) Price (2015-2020)
5.3 Peripheral Nervous System (PNS) Sales Growth Rate and Price
5.3.1 Global Peripheral Nervous System (PNS) Sales Growth Rate (2015-2020)
5.3.2 Global Peripheral Nervous System (PNS) Price (2015-2020)
6 Global Neurologic Disorders Therapeutics Market Segment by Application
6.1 Global Neurologic Disorders Therapeutics Sales Market Share by Application (2015-2020)
6.2 Paralysis Sales Growth Rate (2015-2020)
6.3 Muscle Weakness Sales Growth Rate (2015-2020)
6.4 Poor Coordination Sales Growth Rate (2015-2020)
6.5 Loss of Sensation Sales Growth Rate (2015-2020)
6.6 Seizures Sales Growth Rate (2015-2020)
6.7 Confusion Sales Growth Rate (2015-2020)
6.8 Pain and Altered Levels of Consciousness Sales Growth Rate (2015-2020)
7 Neurologic Disorders Therapeutics Related Market Analysis
7.1 Upstream Analysis
7.1.1 Macro Analysis of Upstream Markets
7.1.2 Key Players in Upstream Markets
7.1.3 Upstream Market Trend Analysis
7.1.4 Neurologic Disorders Therapeutics Manufacturing Cost Analysis
7.2 Downstream Market Analysis
7.2.1 Macro Analysis of Down Markets
7.2.2 Key Players in Down Markets
7.2.3 Downstream Market Trend Analysis
7.2.4 Sales Channel, Distributors, Traders and Dealers
8 Global Neurologic Disorders Therapeutics Market Forecast
8.1 Global Neurologic Disorders Therapeutics Sales, Revenue Forecast
8.1.1 Global Neurologic Disorders Therapeutics Sales Growth Rate Forecast (2020-2025)
8.1.2 Global Neurologic Disorders Therapeutics Revenue and Growth Rate Forecast (2020-2025)
8.1.3 Global Neurologic Disorders Therapeutics Price and Trend Forecast (2020-2025)
8.2 Global Neurologic Disorders Therapeutics Sales Forecast by Region (2020-2025)
8.2.1 North America Neurologic Disorders Therapeutics Sales, Revenue Forecast (2020-2025)
8.2.2 Europe Neurologic Disorders Therapeutics Sales, Revenue Forecast (2020-2025)
8.2.3 Japan Neurologic Disorders Therapeutics Production, Revenue Forecast (2020-2025)
8.2.4 China Neurologic Disorders Therapeutics Production, Revenue Forecast (2020-2025)
9 Research Findings and Conclusion
10 Appendix
List of Figures, Tables and Charts Available in COVID-19's impact to Global Neurologic Disorders Therapeutics Market Research Report 2020, Forecast to 2025
List of Tables and FiguresFigure Neurologic Disorders Therapeutics Picture
Table Global Neurologic Disorders Therapeutics Sales by Type
Figure Global Sales Market Share of Neurologic Disorders Therapeutics by Product Type in 2019
Table Breakdown of Neurologic Disorders Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Figure Neurologic Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure Central Nervous System (CNS) Picture
Figure Peripheral Nervous System (PNS) Picture
Table Global Neurologic Disorders Therapeutics Sales by Application
Figure Global Neurologic Disorders Therapeutics Sales Market Share by Application in 2019
Figure Paralysis Picture
Figure Muscle Weakness Picture
Figure Poor Coordination Picture
Figure Loss of Sensation Picture
Figure Seizures Picture
Figure Confusion Picture
Figure Pain and Altered Levels of Consciousness Picture
Table Neurologic Disorders Therapeutics Market Size Comparison by Region (2019-2025) (K Units) & (Million US$)
Figure Global Neurologic Disorders Therapeutics Revenue (Million US$) (2015-2025)
Figure Global Neurologic Disorders Therapeutics Production (K Units) (2015-2025)
Figure North America Neurologic Disorders Therapeutics Revenue (Million US$) Growth Rate (2015-2025)
Figure Europe Neurologic Disorders Therapeutics Revenue (Million US$) Growth Rate (2015-2025)
Figure Japan Neurologic Disorders Therapeutics Revenue (Million US$) Growth Rate (2014-2025)
Figure China Neurologic Disorders Therapeutics Revenue (Million US$) Growth Rate (2015-2025)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table SWOT Analysis
Table Global Neurologic Disorders Therapeutics Sales by Manufacturer (2018-2020)
Figure Global Neurologic Disorders Therapeutics Sales Market Share by Manufacturer in 2019
Table Global Neurologic Disorders Therapeutics Revenue by Manufacturer (2018-2020)
Figure Global Neurologic Disorders Therapeutics Revenue Market Share by Manufacturer in 2019
Table Global Neurologic Disorders Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Neurologic Disorders Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Neurologic Disorders Therapeutics Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Neurologic Disorders Therapeutics Market
Table Key Manufacturers Neurologic Disorders Therapeutics Product Type
Table Mergers & Acquisitions Planning
Table Biogen Inc. Company Profile
Figure Neurologic Disorders Therapeutics Product Picture and Specifications of Biogen Inc.
Table Neurologic Disorders Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Biogen Inc. Neurologic Disorders Therapeutics Market Share (2018-2020)
Table Biogen Inc. Main Business
Table Biogen Inc. Recent Development
Table F. Hoffmann-La Roche Ltd. Company Profile
Figure Neurologic Disorders Therapeutics Product Picture and Specifications of F. Hoffmann-La Roche Ltd.
Table Neurologic Disorders Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Market Share (2018-2020)
Table F. Hoffmann-La Roche Ltd. Main Business
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Johnson & Johnson Services Inc. Company Profile
Figure Neurologic Disorders Therapeutics Product Picture and Specifications of Johnson & Johnson Services Inc.
Table Neurologic Disorders Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Market Share (2018-2020)
Table Johnson & Johnson Services Inc. Main Business
Table Johnson & Johnson Services Inc. Recent Development
Table Novartis AG Company Profile
Figure Neurologic Disorders Therapeutics Product Picture and Specifications of Novartis AG
Table Neurologic Disorders Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novartis AG Neurologic Disorders Therapeutics Market Share (2018-2020)
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table Pfizer Inc. Company Profile
Figure Neurologic Disorders Therapeutics Product Picture and Specifications of Pfizer Inc.
Table Neurologic Disorders Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pfizer Inc. Neurologic Disorders Therapeutics Market Share (2018-2020)
Table Pfizer Inc. Main Business
Table Pfizer Inc. Recent Development
Table Global Neurologic Disorders Therapeutics Sales (K Units) by Region (2015-2020)
Table Global Neurologic Disorders Therapeutics Sales Market Share by Region (2015-2019)
Figure Global Neurologic Disorders Therapeutics Sales Market Share by Region (2015-2019)
Figure Global Neurologic Disorders Therapeutics Sales Market Share by Region in 2018
Table Global Neurologic Disorders Therapeutics Revenue (Million US$) by Region (2015-2020)
Table Global Neurologic Disorders Therapeutics Revenue Market Share by Region (2015-2020)
Figure Global Neurologic Disorders Therapeutics Revenue Market Share by Region (2015-2020)
Figure Global Neurologic Disorders Therapeutics Revenue Market Share by Region in 2019
Table Global Neurologic Disorders Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Neurologic Disorders Therapeutics Sales (K Units) Growth Rate (2015-2020)
Figure Europe Neurologic Disorders Therapeutics Sales (K Units) Growth Rate (2015-2020)
Table Europe Neurologic Disorders Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Neurologic Disorders Therapeutics Sales (K Units) Growth Rate (2015-2020)
Table Japan Neurologic Disorders Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Neurologic Disorders Therapeutics Sales (K Units) Growth Rate (2015-2020)
Table China Neurologic Disorders Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Neurologic Disorders Therapeutics Sales by Type (2015-2020)
Table Global Neurologic Disorders Therapeutics Sales Market Share by Type (2015-2020)
Figure Global Neurologic Disorders Therapeutics Sales Market Share by Type in 2019
Table Global Neurologic Disorders Therapeutics Revenue by Type (2015-2020)
Table Global Neurologic Disorders Therapeutics Revenue Market Share by Type (2015-2020)
Figure Global Neurologic Disorders Therapeutics Revenue Market Share by Type in 2019
Figure Global Central Nervous System (CNS) Sales Growth Rate (2015-2025)
Figure Global Central Nervous System (CNS) Price (2015-2020)
Figure Global Peripheral Nervous System (PNS) Sales Growth Rate (2015-2025)
Figure Global Peripheral Nervous System (PNS) Price (2015-2020)
Table Global Neurologic Disorders Therapeutics Sales Market Share by Application (2015-2020)
Figure Global Neurologic Disorders Therapeutics Sales Market Share by Application in 2019
Figure Global Paralysis Sales Growth Rate (2015-2025)
Figure Global Muscle Weakness Sales Growth Rate (2015-2025)
Figure Global Poor Coordination Sales Growth Rate (2015-2025)
Figure Global Loss of Sensation Sales Growth Rate (2015-2025)
Figure Global Seizures Sales Growth Rate (2015-2025)
Figure Global Confusion Sales Growth Rate (2015-2025)
Figure Global Pain and Altered Levels of Consciousness Sales Growth Rate (2015-2025)
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurologic Disorders Therapeutics
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Global Neurologic Disorders Therapeutics Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Neurologic Disorders Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Neurologic Disorders Therapeutics Price and Trend Forecast (2020-2025)
Table Global Neurologic Disorders Therapeutics Sales (K Units) Forecast by Region (2020-2025)
Figure Global Neurologic Disorders Therapeutics Production Market Share Forecast by Region (2020-2025)
Figure North America Neurologic Disorders Therapeutics Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Neurologic Disorders Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Neurologic Disorders Therapeutics Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Neurologic Disorders Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Neurologic Disorders Therapeutics Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Neurologic Disorders Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Neurologic Disorders Therapeutics Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Neurologic Disorders Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Keyplayers in COVID-19's impact to Global Neurologic Disorders Therapeutics Market Research Report 2020, Forecast to 2025
Biogen Inc.F. Hoffmann-La Roche Ltd.
Johnson & Johnson Services Inc.
